Literature DB >> 3729972

The nature of microsomal monooxygenase inhibition by cimetidine.

D J Winzor, B Ioannoni, P E Reilly.   

Abstract

A kinetic investigation of the inhibitory effect of cimetidine on the O-dealkylation of 7-ethoxyresorufin by rat liver microsomes has yielded linear Lineweaver-Burk plots which intersect in the second quadrant. Though technically compatible with non-competitive inhibition, the results are shown to be readily explained by the more realistic molecular concept of competitive inhibition by invoking the involvement of cytochrome P-450 isoenzymes with widely different KI values. Microsomal monooxygenase heterogeneity is also shown to provide a plausible explanation of other published results signifying the departure of chloramphenicol and phenacetin from the concept of competitive inhibition despite competition with substrate for the active-site haem group of cytochrome P-450.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3729972     DOI: 10.1016/0006-2952(86)90586-1

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  8 in total

Review 1.  Clinical pharmacokinetics of drugs used in the treatment of gastrointestinal diseases (Part II).

Authors:  K Lauritsen; L S Laursen; J Rask-Madsen
Journal:  Clin Pharmacokinet       Date:  1990-08       Impact factor: 6.447

Review 2.  Dosage regimen of cimetidine reviewed. Possible drug accumulation after multiple oral doses.

Authors:  J Prandota; I J Smith; J T Wilson
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

Review 3.  Clinical pharmacology of antibiotics and other drugs in cystic fibrosis.

Authors:  J Prandota
Journal:  Drugs       Date:  1988-05       Impact factor: 9.546

4.  Kinetics of drug metabolism inhibition: use of metabolite concentration-time profiles.

Authors:  P N Shaw; J B Houston
Journal:  J Pharmacokinet Biopharm       Date:  1987-10

5.  Cimetidine enhances cisplatin toxicity in mice.

Authors:  R T Dorr; M J Soble
Journal:  J Cancer Res Clin Oncol       Date:  1988       Impact factor: 4.553

6.  H2-antagonists and carmustine.

Authors:  R T Dorr; M J Soble
Journal:  J Cancer Res Clin Oncol       Date:  1989       Impact factor: 4.553

Review 7.  Pharmacokinetic interactions of cimetidine 1987.

Authors:  A Somogyi; M Muirhead
Journal:  Clin Pharmacokinet       Date:  1987-05       Impact factor: 6.447

8.  Potent and non-specific inhibition of cytochrome P450 by JM216, a new oral platinum agent.

Authors:  Y Ando; T Shimizu; K Nakamura; T Mushiroda; T Nakagawa; T Kodama; T Kamataki
Journal:  Br J Cancer       Date:  1998-11       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.